Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregation.

Azouzi S, Mikdar M, Hermand P, Gautier EF, Salnot V, Willemetz A, Nicolas G, Vrignaud C, Raneri A, Mayeux P, Bole-Feysot C, Nitschké P, Cartron JP, Colin Y, Hermine O, Jedlitschky G, Cloutier M, Constanzo-Yanez J, Ethier C, Robitaille N, St-Louis M, Le Van Kim C, Peyrard T.

Blood. 2019 Dec 11. pii: blood.2019002320. doi: 10.1182/blood.2019002320. [Epub ahead of print]

PMID:
31826245
2.

Red blood cell autoantibodies: The importance of being earnestly autoadsorbed.

Beguet-Yachine M, Lafarge X, Besiers C, Augis V, Ramelet S, Peyrard T, Thonier V.

Transfus Med. 2019 Nov 26. doi: 10.1111/tme.12648. [Epub ahead of print] No abstract available.

PMID:
31769550
4.

Acute hemolytic transfusion reaction associated with anti-Mta : case report and review of the literature.

Claes V, Peyrard T, Deleers M, El Kenz H.

Transfusion. 2019 Nov;59(11):3314-3318. doi: 10.1111/trf.15521. Epub 2019 Sep 10.

PMID:
31503331
5.

A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes.

Flegel WA, Peyrard T, Chiaroni J, Tournamille C, Jamet D, Pirenne F.

Blood Transfus. 2019 Mar;17(2):89-90. doi: 10.2450/2018.0059-18. Epub 2018 May 3. No abstract available.

6.

International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetings.

Storry JR, Clausen FB, Castilho L, Chen Q, Daniels G, Denomme G, Flegel WA, Gassner C, de Haas M, Hyland C, Yanli J, Keller M, Lomas-Francis C, Nogues N, Olsson ML, Peyrard T, van der Schoot E, Tani Y, Thornton N, Wagner F, Weinstock C, Wendel S, Westhoff C, Yahalom V.

Vox Sang. 2019 Jan;114(1):95-102. doi: 10.1111/vox.12717. Epub 2018 Nov 12.

7.

How to mitigate the risk of inducing transfusion-associated adverse reactions.

Garraud O, Cognasse F, Laradi S, Hamzeh-Cognasse H, Peyrard T, Tissot JD, Fontana S.

Transfus Clin Biol. 2018 Nov;25(4):262-268. doi: 10.1016/j.tracli.2018.07.006. Epub 2018 Jul 27. Review.

PMID:
30139570
8.

Management of the blood supply for a Jk(a-b-) patient with an anti-Jk3 in preparation for an urgent heart transplant: An illustrative example of a successful international cooperation.

Thonier V, Cohen-Bacrie S, Loussert I, Thornton N, Djoudi R, Woimant G, Boulat C, Pirenne F, Peyrard T.

Transfus Clin Biol. 2019 Feb;26(1):48-55. doi: 10.1016/j.tracli.2018.04.002. Epub 2018 May 23.

PMID:
29802018
9.

High immunogenicity of red blood cell antigens restricted to the population of African descent in a cohort of sickle cell disease patients.

Floch A, Gien D, Tournamille C, Chami B, Habibi A, Galactéros F, Bierling P, Djoudi R, Pondarré C, Peyrard T, Pirenne F.

Transfusion. 2018 Jun;58(6):1527-1535. doi: 10.1111/trf.14633. Epub 2018 Apr 29.

PMID:
29707783
10.

Transfusion-associated hazards: A revisit of their presentation.

Garraud O, Sut C, Haddad A, Tariket S, Aloui C, Laradi S, Hamzeh-Cognasse H, Bourlet T, Zeni F, Aubron C, Ozier Y, Laperche S, Peyrard T, Buffet P, Guyotat D, Tavernier E, Cognasse F, Pozzetto B, Andreu G.

Transfus Clin Biol. 2018 May;25(2):118-135. doi: 10.1016/j.tracli.2018.03.002. Epub 2018 Apr 4. Review.

PMID:
29625790
11.

Impact of hydroxycarbamide and interferon-α on red cell adhesion and membrane protein expression in polycythemia vera.

Brusson M, De Grandis M, Cochet S, Bigot S, Marin M, Leduc M, Guillonneau F, Mayeux P, Peyrard T, Chomienne C, Le Van Kim C, Cassinat B, Kiladjian JJ, El Nemer W.

Haematologica. 2018 Jun;103(6):972-981. doi: 10.3324/haematol.2017.182303. Epub 2018 Mar 29.

12.

The Gerbich blood group system: old knowledge, new importance.

Jaskiewicz E, Peyrard T, Kaczmarek R, Zerka A, Jodlowska M, Czerwinski M.

Transfus Med Rev. 2018 Apr;32(2):111-116. doi: 10.1016/j.tmrv.2018.02.004. Epub 2018 Mar 2. Review.

13.

Band 3 phosphorylation induces irreversible alterations of stored red blood cells.

Azouzi S, Romana M, Arashiki N, Takakuwa Y, El Nemer W, Peyrard T, Colin Y, Amireault P, Le Van Kim C.

Am J Hematol. 2018 May;93(5):E110-E112. doi: 10.1002/ajh.25044. Epub 2018 Feb 24. No abstract available.

14.

The Vel blood group system: a review.

Storry JR, Peyrard T.

Immunohematology. 2017 Jun;33(2):56-59. Review.

PMID:
28657763
15.

Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre.

Allali S, Peyrard T, Amiranoff D, Cohen JF, Chalumeau M, Brousse V, de Montalembert M.

Br J Haematol. 2017 May;177(4):641-647. doi: 10.1111/bjh.14609. Epub 2017 Apr 12.

PMID:
28402005
16.

Enhanced calreticulin expression in red cells of polycythemia vera patients harboring the JAK2V617F mutation.

Brusson M, Cochet S, Leduc M, Guillonneau F, Mayeux P, Peyrard T, Chomienne C, Le Van Kim C, Cassinat B, Kiladjian JJ, El Nemer W.

Haematologica. 2017 Jul;102(7):e241-e244. doi: 10.3324/haematol.2016.161604. Epub 2017 Apr 6. No abstract available.

17.

Genetic background of the rare Yus and Gerbich blood group phenotypes: homologous regions of the GYPC gene contribute to deletion alleles.

Gourri E, Denomme GA, Merki Y, Scharberg EA, Vrignaud C, Frey BM, Peyrard T, Gassner C.

Br J Haematol. 2017 May;177(4):630-640. doi: 10.1111/bjh.14578. Epub 2017 Mar 8.

PMID:
28272739
18.

The French national rare blood program.

Peyrard T.

Immunohematology. 2016 Jan;32(1):23-25. Review. No abstract available.

PMID:
27858419
19.

International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings.

Storry JR, Castilho L, Chen Q, Daniels G, Denomme G, Flegel WA, Gassner C, de Haas M, Hyland C, Keller M, Lomas-Francis C, Moulds JM, Nogues N, Olsson ML, Peyrard T, van der Schoot CE, Tani Y, Thornton N, Wagner F, Wendel S, Westhoff C, Yahalom V.

ISBT Sci Ser. 2016 Aug;11(2):118-122. doi: 10.1111/voxs.12280. Epub 2016 Jun 27.

20.

Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients.

Ibanez C, Habibi A, Mekontso-Dessap A, Chadebech P, Chami B, Bierling P, Galactéros F, Rieux C, Nataf J, Bartolucci P, Peyrard T, Pirenne F.

Transfusion. 2016 Jul;56(7):1828-33. doi: 10.1111/trf.13611. Epub 2016 May 3.

PMID:
27145018
21.

[Difficulties of the care of public antigen alloimmunization].

Ben Amor I, Rekik T, Louati N, Lahiani W, Rekik H, Peyrard T, Menif H, Gargouri J.

Transfus Clin Biol. 2016 May;23(2):103-5. doi: 10.1016/j.tracli.2015.12.008. Epub 2016 Jan 27. French.

PMID:
26826911
22.

Characterization of a new human monoclonal antibody directed against the Vel antigen.

Danger Y, Danard S, Gringoire V, Peyrard T, Riou P, Semana G, Vérité F.

Vox Sang. 2016 Feb;110(2):172-8. doi: 10.1111/vox.12321. Epub 2015 Sep 18.

PMID:
26382919
23.

A novel GYPB-A-B hybrid gene responsible for Ss and MN typing discrepancies.

Willemetz A, Nataf J, Peyrard T, Arnaud L.

Transfusion. 2015 Nov;55(11):2620-3. doi: 10.1111/trf.13216. Epub 2015 Aug 6.

PMID:
26247620
24.

Identification of the Molecular and Genetic Basis of PX2, a Glycosphingolipid Blood Group Antigen Lacking on Globoside-deficient Erythrocytes.

Westman JS, Benktander J, Storry JR, Peyrard T, Hult AK, Hellberg Å, Teneberg S, Olsson ML.

J Biol Chem. 2015 Jul 24;290(30):18505-18. doi: 10.1074/jbc.M115.655308. Epub 2015 Jun 8.

25.

Management of a pregnant woman with anti-holley alloantibody.

Braschler T, Vökt CA, Hustinx H, Peyrard T, Infanti L, Buser A, Holbro A.

Transfus Med Hemother. 2015 Mar;42(2):129-30. doi: 10.1159/000371499. Epub 2015 Jan 29.

26.

Lack of the nucleoside transporter ENT1 results in the Augustine-null blood type and ectopic mineralization.

Daniels G, Ballif BA, Helias V, Saison C, Grimsley S, Mannessier L, Hustinx H, Lee E, Cartron JP, Peyrard T, Arnaud L.

Blood. 2015 Jun 4;125(23):3651-4. doi: 10.1182/blood-2015-03-631598. Epub 2015 Apr 20.

27.

Gene conversion events between GYPB and GYPE abolish expression of the S and s blood group antigens.

Willemetz A, Nataf J, Thonier V, Peyrard T, Arnaud L.

Vox Sang. 2015 May;108(4):410-6. doi: 10.1111/vox.12244. Epub 2015 Mar 4.

PMID:
25740598
28.

Short duplication within the RHCE gene associated with an in cis deleted RHD causing a Rhnull amorph phenotype in an immunized pregnant woman with anti-Rh29.

Silvy M, Beley S, Peyrard T, Ouchari M, Abdelkefi S, Jemni Yacoub S, Chiaroni J, Bailly P.

Transfusion. 2015 Jun;55(6 Pt 2):1407-10. doi: 10.1111/trf.12937. Epub 2014 Nov 21.

PMID:
25413218
29.

Family study of a Swiss patient uncovered a novel genetic basis for the S-s-U+(var) phenotype.

Saison C, Waldvogel S, Gien D, Peyrard T, Arnaud L.

Transfusion. 2014 Nov;54(11):2941-5. doi: 10.1111/trf.12681. Epub 2014 Apr 17.

PMID:
24738877
30.

The LAN blood group system:a review.

Peyrard T.

Immunohematology. 2013;29(4):131-5. Review.

PMID:
24689682
31.

Large deletions involving the regulatory upstream regions of A4GALT give rise to principally novel P1PK-null alleles.

Westman JS, Hellberg A, Peyrard T, Thuresson B, Olsson ML.

Transfusion. 2014 Jul;54(7):1831-5. doi: 10.1111/trf.12543. Epub 2014 Jan 14.

PMID:
24417201
32.

P1/P2 genotyping of known and novel null alleles in the P1PK and GLOB histo-blood group systems.

Westman JS, Hellberg A, Peyrard T, Hustinx H, Thuresson B, Olsson ML.

Transfusion. 2013 Nov;53(11 Suppl 2):2928-39. doi: 10.1111/trf.12355. Epub 2013 Aug 8.

PMID:
23927681
33.

[A KEL*02mod allele responsible for an apparent maternity exclusion].

Monfort M, Peyrard T, Arnaud L, Helias V, Maggipinto G, Gérard C.

Transfus Clin Biol. 2013 Dec;20(5-6):490-5. doi: 10.1016/j.tracli.2013.03.278. Epub 2013 May 30. French.

PMID:
23727116
34.

Molecular basis of two novel and related high-prevalence antigens in the Kell blood group system, KUCI and KANT, and their serologic and spatial association with K11 and KETI.

Velliquette RW, Hue-Roye K, Lomas-Francis C, Gillen B, Schierts J, Gentzkow K, Peyrard T, von Zabern I, Flegel WA, Rodberg K, Debnath AK, Lee S, Reid ME.

Transfusion. 2013 Nov;53(11 Suppl 2):2872-81. doi: 10.1111/trf.12200. Epub 2013 Apr 8.

35.

Disruption of SMIM1 causes the Vel- blood type.

Ballif BA, Helias V, Peyrard T, Menanteau C, Saison C, Lucien N, Bourgouin S, Le Gall M, Cartron JP, Arnaud L.

EMBO Mol Med. 2013 May;5(5):751-61. doi: 10.1002/emmm.201302466. Epub 2013 Apr 15.

36.

Molecular analysis of the rare in(Lu) blood type: toward decoding the phenotypic outcome of haploinsufficiency for the transcription factor KLF1.

Helias V, Saison C, Peyrard T, Vera E, Prehu C, Cartron JP, Arnaud L.

Hum Mutat. 2013 Jan;34(1):221-8. doi: 10.1002/humu.22218. Epub 2012 Nov 2.

PMID:
23125034
37.

The ABCB6 mutation p.Arg192Trp is a recessive mutation causing the Lan- blood type.

Saison C, Helias V, Peyrard T, Merad L, Cartron JP, Arnaud L.

Vox Sang. 2013 Feb;104(2):159-65. doi: 10.1111/j.1423-0410.2012.01650.x. Epub 2012 Sep 10.

PMID:
22958180
38.

Structural basis for the ABO blood-group dependence of Plasmodium falciparum rosetting.

Vigan-Womas I, Guillotte M, Juillerat A, Hessel A, Raynal B, England P, Cohen JH, Bertrand O, Peyrard T, Bentley GA, Lewit-Bentley A, Mercereau-Puijalon O.

PLoS Pathog. 2012;8(7):e1002781. doi: 10.1371/journal.ppat.1002781. Epub 2012 Jul 12.

39.

RHD*DOL1 and RHD*DOL2 encode a partial D antigen and are in cis with the rare RHCE*ceBI allele in people of African descent.

Roussel M, Poupel S, Nataf J, Juszczak G, Woimant G, Mailloux A, Menanteau C, Pham BN, Rouger P, Le Pennec PY, Peyrard T.

Transfusion. 2013 Feb;53(2):363-72. doi: 10.1111/j.1537-2995.2012.03743.x. Epub 2012 Jun 13.

PMID:
22690701
40.

A new AQP1 null allele identified in a Gypsy woman who developed an anti-CO3 during her first pregnancy.

Saison C, Peyrard T, Landre C, Ballif BA, Schlosser KA, Dettori I, Chicheportiche C, Nemeth P, Cartron JP, Arnaud L.

Vox Sang. 2012 Aug;103(2):137-44. doi: 10.1111/j.1423-0410.2012.01590.x. Epub 2012 Feb 20.

41.

[Guidelines for blood transfusion teaching to medical laboratory technology students].

Moncharmont P, Tourlourat M, Fourcade C, Julien E, Peyrard T, Cabaud JJ; Groupe Recherche et démarche qualité de la Société française de transfusion sanguine.

Transfus Clin Biol. 2012 Feb;19(1):46-8. doi: 10.1016/j.tracli.2011.10.002. Epub 2012 Jan 24. French.

PMID:
22269087
42.

ABCB6 is dispensable for erythropoiesis and specifies the new blood group system Langereis.

Helias V, Saison C, Ballif BA, Peyrard T, Takahashi J, Takahashi H, Tanaka M, Deybach JC, Puy H, Le Gall M, Sureau C, Pham BN, Le Pennec PY, Tani Y, Cartron JP, Arnaud L.

Nat Genet. 2012 Jan 15;44(2):170-3. doi: 10.1038/ng.1069.

43.

Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior.

Saison C, Helias V, Ballif BA, Peyrard T, Puy H, Miyazaki T, Perrot S, Vayssier-Taussat M, Waldner M, Le Pennec PY, Cartron JP, Arnaud L.

Nat Genet. 2012 Jan 15;44(2):174-7. doi: 10.1038/ng.1070.

44.

Proof of principle for transfusion of in vitro-generated red blood cells.

Giarratana MC, Rouard H, Dumont A, Kiger L, Safeukui I, Le Pennec PY, François S, Trugnan G, Peyrard T, Marie T, Jolly S, Hebert N, Mazurier C, Mario N, Harmand L, Lapillonne H, Devaux JY, Douay L.

Blood. 2011 Nov 10;118(19):5071-9. doi: 10.1182/blood-2011-06-362038. Epub 2011 Sep 1.

45.

Anti-U-like as an alloantibody in S-s-U- and S-s-U+(var) black people.

Peyrard T, Lam Y, Saison C, Arnaud L, Babinet J, Rouger P, Bierling P, Janvier D.

Transfusion. 2012 Mar;52(3):622-8. doi: 10.1111/j.1537-2995.2011.03318.x. Epub 2011 Aug 31.

PMID:
21880045
46.

Anti-D investigations in individuals expressing weak D Type 1 or weak D Type 2: allo- or autoantibodies?

Pham BN, Roussel M, Peyrard T, Beolet M, Jan-Lasserre V, Gien D, Ripaux M, Bourgouin S, Kappler-Gratias S, Rouger P, Le Pennec PY.

Transfusion. 2011 Dec;51(12):2679-85. doi: 10.1111/j.1537-2995.2011.03207.x. Epub 2011 Jun 9.

PMID:
21658048
47.

Banking of pluripotent adult stem cells as an unlimited source for red blood cell production: potential applications for alloimmunized patients and rare blood challenges.

Peyrard T, Bardiaux L, Krause C, Kobari L, Lapillonne H, Andreu G, Douay L.

Transfus Med Rev. 2011 Jul;25(3):206-16. doi: 10.1016/j.tmrv.2011.01.002. Epub 2011 Mar 4. Review.

PMID:
21377319
48.

Analysis of RhCE variants among 806 individuals in France: considerations for transfusion safety, with emphasis on patients with sickle cell disease.

Pham BN, Peyrard T, Juszczak G, Beolet M, Deram G, Martin-Blanc S, Dubeaux I, Roussel M, Kappler-Gratias S, Gien D, Poupel S, Rouger P, Le Pennec PY.

Transfusion. 2011 Jun;51(6):1249-60. doi: 10.1111/j.1537-2995.2010.02970.x. Epub 2010 Dec 16.

PMID:
21166680
49.

A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia.

Arnaud L, Saison C, Helias V, Lucien N, Steschenko D, Giarratana MC, Prehu C, Foliguet B, Montout L, de Brevern AG, Francina A, Ripoche P, Fenneteau O, Da Costa L, Peyrard T, Coghlan G, Illum N, Birgens H, Tamary H, Iolascon A, Delaunay J, Tchernia G, Cartron JP.

Am J Hum Genet. 2010 Nov 12;87(5):721-7. doi: 10.1016/j.ajhg.2010.10.010. Epub 2010 Nov 4.

50.

A review of the Colton blood group system.

Halverson GR, Peyrard T.

Immunohematology. 2010;26(1):22-6. Review. No abstract available.

PMID:
20795314

Supplemental Content

Loading ...
Support Center